Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST)

Language
en
Document Type
Article
Issue Date
2015-04-22
Issue Year
2015
Authors
Kramer, Klaus
Knippschild, Uwe
Mayer, Benjamin
Bögelspacher, Kira
Spatz, Hanno
Henne-Bruns, Doris
Agaimy, Abbas
Schwab, Matthias
Schmieder, Michael
Editor
Abstract

Background Risk classification and prediction of prognosis in GIST is still a matter of debate. Data on the impact of age and gender as potential confounding factors are limited. Therefore we comprehensively investigated age and gender as independent risk factors for GIST. Methods Two independent patient cohorts (cohort I, n = 87 [<50 years]; cohort II, n = 125 [≥50 years]) were extracted from the multicentre Ulmer GIST registry including a total of 659 GIST patients retrospectively collected in 18 collaborative German oncological centers. Based on demographic and clinicopathological parameters and a median follow-up time of 4.3 years (range 0.56; 21.33) disease-specific-survival (DSS), disease-free-survival (DFS) and overall survival (OS) were calculated. Results GIST patients older than fifty years showed significantly worse DSS compared to younger patients (p = 0.021; HR = 0.307, 95% CI [0.113; 0.834]). DSS was significantly more favorable in younger female GIST patients compared with elderly females (p = 0.008). Female gender resulted again in better prognosis in younger patients (p = 0.033). Conclusions Patient age (<50 years) and female gender were significantly associated with a more favourable prognosis in GIST. Extended studies are warranted to confirm our clinical results and to elucidate underlying pathophysiological mechanisms.

Journal Title
BMC Cancer
Volume
15
Citation
BMC Cancer 15 (2015):S. 57 - 66. <http://www.biomedcentral.com/1471-2407/15/57>
DOI
Zugehörige ORCIDs